Related Experiment Video
Updated: Aug 5, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Initiation of Medication for Alcohol Use Disorder for Inpatients with Alcohol Withdrawal Syndromes
Raman Krimpuri1, Cathrine Youngs1, Charles Emerman1
1Division of Addiction Medicine, Department of Emergency Medicine, Case Western Reserve University, Cleveland, Ohio.
Objective:
Medications for alcohol use disorder (MAUD) are thought to be underused in the United States. This study reviewed data from a national database to determine the frequency of prescribing MAUD for patients admitted to the hospital or discharged with alcohol withdrawal syndromes (AWS).
Method:
We searched for hospital admissions from 2019 to 2021 in the Epic Cosmos database associated with an active diagnosis of AWS. We then searched for patients prescribed medications approved for therapy. We reviewed 197,375 admissions with an active diagnosis of AWS.
Results:
There was an increasing percentage of admissions for AWS from 2019 to 2021. Overall, only 7% of patients were prescribed MAUD at discharge. Naltrexone was the most prescribed MAUD. Women, non-African Americans, Latinos, and patients under 65 were more likely to be prescribed MAUD.
Conclusions:
Many patients with AWS during admission are not prescribed MAUD at the time of discharge.
More Related Videos
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
05:40The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Mania and Antimanic Drugs: Overview
Drug Dependence